Mouse mastocytoma P815 expresses tumor antigens P815A and P815B encoded by a single gene called P1A and carried by a single peptide named P1A 35-43 (NH2-Leu-Pro-Tyr-Leu-Gly-Trp-Leu-Val-Phe-COOH). P1A 35-43 is presented to anti-P815A and anti-P815B cytotoxic T lymphocytes (CTL) by major histocompatibility complex (MHC) H-2Ld molecules. In order to determine the individual role played by each amino acid residue of P1A 35-43 in binding to H-2Ld and in recognition by anti-A and anti-B T cell receptors (TcR), a series of P1A35-43 peptides substituted by alanine at single positions was synthesized and tested for binding to H-2Ld and for CTL recognition. Binding to H-2Ld was estimated by measuring the ability of the peptide to up-regulate cell sur...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
AbstractFor the structural analysis of T-cell receptor (TCR) and peptide/MHC interaction, a series o...
The immunotherapy of cancer aims to activate both the humoral and cellular arms of the immune system...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Immunization of DBA/2 (H-2d) mice with syngeneic P815 tumor cell transfectants that express HLA clas...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Cytotoxic T lymphocytes (CTL) recognize peptides presented at the cell surface in association with m...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
Murine mastocytoma P815 induces CTL responses against at least four distinct Ags (AB, C, D, and E), ...
We showed previously that mouse mastocytoma P815 expresses several distinct antigens that are recogn...
Characterization of epitopes recognized by cytotoxic T lymphocytes (CTLs) in the sequence of tumor a...
Cytotoxic T lymphocytes (CTL) recognize and lyse cells presenting viral or tumor-associated antigens...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
Class I-restricted CD8+ cytotoxic T lymphocytes (CTL) against the circumsporozoite protein (CSP) pro...
This thesis presents data of analysing T cell responses to synthetic Ras peptides and to natural pep...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
AbstractFor the structural analysis of T-cell receptor (TCR) and peptide/MHC interaction, a series o...
The immunotherapy of cancer aims to activate both the humoral and cellular arms of the immune system...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Immunization of DBA/2 (H-2d) mice with syngeneic P815 tumor cell transfectants that express HLA clas...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Cytotoxic T lymphocytes (CTL) recognize peptides presented at the cell surface in association with m...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
Murine mastocytoma P815 induces CTL responses against at least four distinct Ags (AB, C, D, and E), ...
We showed previously that mouse mastocytoma P815 expresses several distinct antigens that are recogn...
Characterization of epitopes recognized by cytotoxic T lymphocytes (CTLs) in the sequence of tumor a...
Cytotoxic T lymphocytes (CTL) recognize and lyse cells presenting viral or tumor-associated antigens...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
Class I-restricted CD8+ cytotoxic T lymphocytes (CTL) against the circumsporozoite protein (CSP) pro...
This thesis presents data of analysing T cell responses to synthetic Ras peptides and to natural pep...
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoc...
AbstractFor the structural analysis of T-cell receptor (TCR) and peptide/MHC interaction, a series o...
The immunotherapy of cancer aims to activate both the humoral and cellular arms of the immune system...